SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " ATM " 2,413 found 🔀 AI-powered Shuffle
MEAS Researchers Lead $1M NSF Project Using AI to Forecast Coastal Dead Zones | Marine, Earth and Atmospheric Sciences
The team aims to produce faster forecasting tools that could support fisheries management and decision-making in Gulf Coast communities.
Scientists Release Biggest 2D Map of the Universe
Key Takeaways The DESI Legacy Imaging Surveys combined more than 263,000 telescope exposures to make the largest 2D map of the universe in visible and near-infrared light. Astronomers can pair the Legacy Surveys map with their own observations to explore our universe and search for rare phenomena. The 2D map serves as the foundation for the Dark Energy Spectroscopic Instrument survey to measure the universe in 3D and investigate dark energy. Hold on to your telescopes: the DESI Legacy Imaging Surveys team has released the largest-ever 2D color map of the universe. The 5.6-trillion-pixel map contains nearly 4 billion celestial objects, primarily stars and galaxies. The data is available for all to use and publicly viewable through the Legacy Survey Sky Viewer. Astronomers and citizen scientists can explore the map or combine it with their own observations to better understand our universe. Researchers can search for rare phenomena like gravitational lenses, observe fleeting events like supernovae, and investigate two of physics’ biggest mysteries: dark matter, the invisible substance that accounts for most of the mass in our universe, and dark energy, the force driving our universe’s accelerating expansion. The new map builds on earlier versions from the DESI Legacy Imaging Surveys that have already proved invaluable. To date, more than 1,800 science papers that reference the Legacy Surveys data have been published. “It’s part of the fabric of astronomy research now,” said David Schlegel, a co-lead of the Legacy Surveys and scientist at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab). “When you’re working with astronomical objects today, you often start by pulling up the Legacy Imaging Viewer to see what you’re looking at.” Covering roughly 75% of the sky in visible and near-infrared light, the updated map provides a deep view of the extragalactic universe not blocked by the dust and stars of our own Milky Way. Researchers expect it will remain the most comprehensive 2D map of our universe for years to come. More than 160 scientists contributed to data collection for the project, and a team of 20 produced the final dataset released today. It was built by combining 263,407 telescope exposures from three ground-based sky surveys: the Dark Energy Camera Legacy Survey (DECaLS) at NSF Cerro Tololo Inter-American Observatory, the Mayall z-band Legacy Survey (MzLS) at NSF Kitt Peak National Observatory, and the Beijing-Arizona Sky Survey (BASS) at the University of Arizona’s Steward Observatory. That was supplemented by years of data from NASA’s Wide-field Infrared Survey Explorer (WISE) satellite mission and additional public data. “For our team, these data are fundamental to our investigation of the expansion history of the universe and the formation of our galaxy,” said Arjun Dey, co-lead of the Legacy Surveys and an astronomer at NSF NOIRLab. “But the skies belong to everyone, and this survey gives everyone the chance to explore the sky and marvel at its wonders.” Here be galaxies The DESI Legacy Imaging Surveys were originally conducted to prepare for the Dark Energy Spectroscopic Instrument (DESI) survey. The Legacy Surveys’ 2D map is essentially a deep photograph of the sky; it records where galaxies and stars appear and how bright they appear. This crucial step enables DESI to select objects and measure their light in different wavelengths to determine their distances, building the largest high-resolution 3D map ever made. Scientists study the way galaxies have clustered at different ages of the universe to track dark energy over time. In April 2026, DESI completed its original five-year survey ahead of schedule and with vastly more objects than expected. The early results have shown surprising hints that dark energy’s impact may be weakening over time — a paradigm shift that could potentially shape the predicted fate of our universe. DESI expects to publish improved results using their first five years of data in 2027 and is continuing observations into 2028. DESI was so efficient at observing galaxies, the Legacy Surveys map needed to expand. Early on, “it became clear we might run out of galaxies to look at and run out of sky, and we better start doing something about that,” said Schlegel, who also works on DESI. The new Legacy Surveys map has been used to select DESI targets since June 2026 and will guide the telescope’s operations over the coming years. Computing the cosmos Merging hundreds of thousands of images taken on 2,285 nights, each with unique atmospheric and telescope conditions, was a massive computational effort. It took about a year to develop the computer code and eight weeks to process all the images at the Perlmutter supercomputer at the National Energy Research Scientific Computing Center (NERSC) at Berkeley Lab. Beyond supporting DESI, the Legacy Surveys will be a foundational reference for the next generation of telescopes. As new observatories like the NSF-DOE Vera C. Rubin Observatory (jointly funded by NSF and DOE’s Office of Science) and NASA’s Nancy Grace Roman Space Telescope come online, researchers can compare their observations with one of the deepest and most comprehensive views of the sky ever assembled. The Legacy Surveys data will also help scientists train artificial intelligence tools to analyze petabytes of astronomical data and accelerate new discoveries. It will be among the datasets used in an astrophysics pilot project within the American Science Cloud, part of the DOE’s Genesis Mission. The DESI Legacy Imaging Surveys are supported by the U.S. Department of Energy’s Office of High Energy Physics; the National Energy Research Scientific Computing Center, a DOE Office of Science user facility; the U.S. National Science Foundation, Division of Astronomical Sciences; and the partner institutions. DESI is supported by the DOE Office of Science and NERSC. Additional support for DESI is provided by the NSF; the Science and Technology Facilities Council of the United Kingdom; the Gordon and Betty Moore Foundation; the Heising-Simons Foundation; the French Alternative Energies and Atomic Energy Commission (CEA); the Secretariat of Science, Humanities, Technology and Innovation (SECIHTI) of Mexico; the Ministry of Science and Innovation of Spain; and by the DESI member institutions. ### Lawrence Berkeley National Laboratory (Berkeley Lab) is committed to groundbreaking research focused on discovery science and solutions for abundant and reliable energy supplies. The lab’s expertise spans materials, chemistry, physics, biology, earth and environmental science, mathematics, and computing. Researchers from around the world rely on the lab’s world-class scientific facilities for their own pioneering research. Founded in 1931 on the belief that the biggest problems are best addressed by teams, Berkeley Lab and its scientists have been recognized with 17 Nobel Prizes. Berkeley Lab is a multiprogram national laboratory managed by the University of California for the U.S. Department of Energy’s Office of Science. DOE’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit energy.gov/science.
AbCellera women’s health data top ‘most aggressive upside scenario,’ putting Astellas and Bayer on notice
AbCellera has reported phase 2 results “beyond even the most aggressive upside scenario” that its CEO dared to consider, boosting the biotech’s chances of challenging Astellas and Bayer for a women’s health market. The phase 2 clinical trial compared ABCL635, an antibody targeting NK3R, to placebo in patients with hot flashes caused by menopause. Investigators enrolled 92 postmenopausal women experiencing a mean of about 10 moderate or severe hot flashes per day. By Week 4, the number of moderate or severe hot flashes had fallen by a mean of 8.8 on ABCL635 and by 3.5 on placebo. That statistically significant, placebo-adjusted reduction of 5.3 hit the trial’s primary endpoint. The level of efficacy also cleared the bar set by existing drugs. While cross-trial comparisons can be misleading, AbCellera CEO Carl Hansen, Ph.D., had seen enough to start hyping the program. “We now view ABCL635 as a potential best-in-class non-hormonal therapy with strong differentiation against approved NK3R competitors across all important dimensions, including efficacy, safety, dosing and convenience,” Hansen said on a Monday morning conference call with investors to discuss the data. “We believe ABCL635 is now a highly de-risked program.” Last week, Hansen used AbCellera’s earnings call to set expectations for readout, with the CEO defining success as a clean safety profile and efficacy comparable to the two approved small molecules. The data vaulted over that bar. Astellas linked (PDF) one of the small molecules, Veozah, to placebo-adjusted reductions in hot flash frequency of 2.1 and 2.6 at Week 4 of its two phase 3 trials. Bayer reported (PDF) placebo-adjusted reductions of 3.04 and 3.29 at Week 4 of pivotal studies for its small molecule, Lynkuet. At 5.3, the placebo-adjusted reduction in AbCellera’s trial comfortably cleared the standard set by the incumbents. Veozah and Lynkuet came to market based on evidence of their ability to reduce the frequency and severity of hot flashes. AbCellera’s phase 2 study covered both endpoints, with the Canadian biotech reporting a mean reduction in severity of 1.4 points at Week 4 on ABCL635, compared to 0.3 points for placebo. Again, the placebo-adjusted result compares favorably to data on Veozah and Lynkuet. Analysts shared Hansen’s enthusiasm for the data. The phase 2 results “firmly validate ABCL635 as a potentially best-in-class treatment,” BMO Capital Markets analysts said in a note to investors Monday. ABCL635’s apparent efficacy edge “is likely attributable to the higher dosing/target engagement the asset is able to reach vs. the oral agents due to its wider therapeutic index,” the analysts added. The analysts, who model $2.3 billion in unadjusted peak sales for ABCL635, flagged the safety profile as another positive of the phase 2 readout. While Veozah carries a boxed warning for liver damage, nobody on ABCL635 in the phase 2 trial had elevated liver enzymes or bilirubin values. If replicated in phase 3, the lack of a liver signal could allow approval without the monitoring requirements imposed on Veozah. Investors appeared equally enthused, sending AbCellera's stock up 32% to $9.21 in premarket trading Monday from a Friday closing price of $6.93. Next, AbCellera will collect the Week 12 data and talk to its advisors about further development. The results open up “a wide variety of possibilities of how we might take this forward into phase 3 studies to truly maximize the value of the asset and make sure that ABCL635 is able to demonstrate its differentiation potential,” Sarah Noonberg, M.D., Ph.D., AbCellera’s chief medical officer, told investors.
Lindsay Clancy murder trial resumes with mental health treatment in focus
Former FBI special agent James Gagliano joins 'Fox & Friends First' to discuss the resumption of the Lindsay Clancy murder trial in Plymouth, Massachusetts, focusing on the defense's insanity plea.
The sun will vanish over Europe in a rare total solar eclipse: Watch live
A total solar eclipse will plunge parts of Europe into darkness on August 12, 2026, with Spain offering some of the best views. ESA will livestream the spectacle from the Javalambre Observatory, combining telescope feeds, drone footage, and expert commentary. At 20:31 CEST, the observatory will experience 1 minute and 21 seconds of totality, revealing the Sun’s normally hidden outer atmosphere.
Italian scientists ready new solar instrument for high-stakes eclipse test
Sheltered from the blazing summer sun, a group of scientists in the northern Italian city of Padua spent weeks in a laboratory finalising an instrument they say could transform the study of the solar corona, the outer layer of the sun's atmosphere.
Marblehead resident makes beef his business
MARBLEHEAD — One month after opening Max’s Backyard Beef, owner Max Scivetti said the restaurant is beginning to build the kind of community atmosphere that first inspired him to get… Related posts: Marblehead offers an opportunity to drive your dream car Sophia Harris: Just questions. No answers. 30 Marblehead students snowbound in Paris Senator Markey […]
Bride-to-be sounds alarm after popular beauty treatment left her disfigured before the big day
Ergin 'Batman' Tek calls for small business push to rebuild middle class, construction of Tampa Bay Flood Barrier
'While we have the best healthcare in the world, what good does it make if we can’t afford it?'
This may be one of the most stunning parts of a total eclipse
Despite advances in science, the corona, or outermost part of the sun’s atmosphere, remains mysterious. Wednesday’s total solar eclipse provides a chance to study it.
Thunder Entertainment announces auditions for drummers and Storm Chasers in OKC
Thunder Entertainment is giving fans the chance to join Oklahoma City’s "Loud City" atmosphere by hosting auditions for the Thunder Drummers and Storm Chasers later this month.
Tommy John misses Old-Timers' Day to continue cancer treatment
NEW YORK – Tommy John, whose Major League pitching career was extended by a revolutionary elbow procedure that now carries his name, penned an emotional statement addressing the Yankees and their fans ahead of Saturday’s Old-Timers’ Day festivities at Yankee Stadium. “I want to thank the Yankees organization and the
A tragedy & a trial shine a spotlight on new moms’ mental health
The Lindsay Clancy trial shines a spotlight on postpartum psychosis and other forms of perinatal mental health issues; treatment and education are vital and available
Missouri should dump the use of junk science in its courtrooms
Missouri patients deserve confidence that the science presented in our courtrooms is credible, reliable and grounded in evidence. When unreliable expert testimony is allowed to influence juries, the consequences extend far beyond the courtroom. Manufactured claims can scare patients away from proven treatments and make medical innovators think twice about investing in research and development […]
Allegheny Health Network first in Western Pa. to offer GammaTile brain cancer treatment
Trailblazing technology offered at Allegheny General Hospital in Pittsburgh’s North Side is helping patients with operable brain metastases live longer. Allegheny Health Network neurosurgeon Matthew J. Shepard is the first physician in Western Pennsylvania to use GammaTile, an FDA-approved treatment that uses collagen disks about the size of postage stamps
East Hampton residents cite health worries amid battery plant fire investigation
The town supervisor called on the battery plant operator to adopt safety upgrades or risk a shutdown.
AI just created a virus not found in nature and scientists are worried
The technique could lead to new treatments for antibiotic-resistant bugs, but some scientists say the technology could be misused
Batman Makes You Nicer. Science Just Proved It.
A social experiment found that people acted more chivalrous when someone dressed as the Caped Crusader was nearby.
Vitamin C may fight cancer — but not the way scientists once thought
Linus Pauling was widely mocked for claiming that vitamin C could fight cancer, especially after trials using vitamin C pills showed no benefit. Researchers now know that intravenous vitamin C reaches vastly higher concentrations and can behave more like an experimental cancer drug than an ordinary supplement. Early studies suggest it may damage vulnerable cancer cells, reduce treatment side effects, and possibly improve outcomes for some patients.
Business Restructuring Review Vol. 25 No. 4 July-August 2026
In This Issue New York Bankruptcy Court: Premature Allegations of Creditor Mistreatment Insufficient to Deny Chapter 15 Recognition of Foreign Restructuring Proceeding In In re ARD Finance, S.A., No. 25-12794 (MG), 2026 WL 817458 (Bankr. S.D.N.Y. Mar. 25, 2026), the U.S. Bankruptcy Court for the Southern District of New York was presented with a petition seeking chapter 15 recognition of Luxembourg's recently enacted bankruptcy law governing judicial reorganization proceedings. The court granted the petition, turning aside challenges to recognition voiced by a creditor group arguing that recognition should be denied based upon allegations of unfairness to creditors in the Luxembourg proceeding that would make recognition manifestly contrary to U.S. public policy. According to the bankruptcy court, recognition was warranted because: (i) the rules and procedures governing the proceeding under Luxembourg law were fundamentally fair; (ii) the petition otherwise satisfied chapter 15's recognition requirements; and (iii) the creditor group's allegations were premature, given the fact that the Luxembourg court presiding over the debtor's restructuring proceeding had not confirmed a restructuring plan, and all creditors had the right to participate fully and voice their objections in the proceeding (including the right to appeal an order approving a plan). [read more …] Florida Bankruptcy Court Examines Scope of Discovery in Chapter 15 Cases In In re Banco Master, S.A., No. 25-24568-SMG, 2026 WL 931729 (Bankr. S.D. Fla. Apr. 6, 2026), the U.S. Bankruptcy Court for the Southern District of Florida granted in part and denied in part post-recognition motions filed by an insider of a foreign debtor seeking to bar or limit discovery sought by the debtor's foreign representative concerning allegedly voidable transfers involving the debtors' U.S. real property. According to the court: (i) although chapter 15 includes its own discovery provisions among the relief that may be granted to a foreign representative, the expansive discovery available in cases under other chapters of the Bankruptcy Code is also available in chapter 15 cases; (ii) the discovery sought by the foreign representative was permissible; (iii) discovery regarding matters that were the subject of a pending adversary proceeding had to be undertaken under the more restrictive rules applicable to such proceedings; and (iv) a discovery request would be barred to the extent that it sought production of documents or testimony from a subpoenaed entity that exceeded the geographic limitations specified in such rules. [read more …] Delaware District Court Affirms Chapter 15 Recognition Order Enforcing Nonconsensual Third-Party Releases In U.S. Int'l Dev. Fin. Corp. v. Credito Real S.A.B. de C.V. SOFOM, E.N.R. (In re Credito Real S.A.B. de C.V. SOFOM, E.N.R.), 677 B.R. 192 (D. Del. 2026), appeal filed, No. 26-2356 (3d Cir. June 5, 2026), the U.S. District Court for the District of Delaware affirmed a bankruptcy court order granting chapter 15 recognition to a Mexican "concurso mercantile" proceeding and enforcing nonconsensual third-party releases approved by the Mexican court. Agreeing with the bankruptcy court that the releases were not manifestly contrary to U.S. public policy, the district court concluded: "It is well settled that U.S. bankruptcy courts can give effect to foreign orders in recognized foreign proceedings pursuant to the authority granted in Chapter 15, even when those orders contain relief unavailable under U.S. law. [The appellant's] arguments misconstrue the Supreme Court's narrow holding in Purdue, applicable in Chapter 11 cases, as well as the statutory framework of Chapter 15 and its core policy objectives. Accordingly, I will affirm the Enforcement Order." The ruling has been appealed to the U.S. Court of Appeals for the Third Circuit. [read more …] Fifth Circuit: Bankruptcy Court, Not State Court, Had Jurisdiction to Allow or Disallow Administrative Expense Claim In Storey Minerals Ltd. v. EP Energy E&P Co., LP (Matter of EP Energy E&P Co., LP), 169 F.4th 609 (5th Cir. 2026), the U.S. Court of Appeals for the Fifth Circuit affirmed lower courts' rulings disallowing a creditor's administrative expense claim. It also rejected the creditor's argument that, because the claims were predicated on state law, a state court should adjudicate the merits of the state law causes of action before the bankruptcy court could allow or disallow the claim as an administrative expense. According to the Fifth Circuit, even though the causes of action were based on state law, the bankruptcy court had jurisdiction to determine whether the creditor's claims should be conferred with administrative expense priority in the debtors' chapter 11 case. [read more …] New York Bankruptcy Court: Dismissal of Involuntary Chapter 11 Case Filed Prior to Commencement of Foreign Restructuring Proceeding Unwarranted In In re Xinyuan Real Estate Co. Ltd., No. 25-10745 (PB), 2026 WL 592250 (Bankr. S.D.N.Y. Mar. 3. 2026), the U.S. Bankruptcy Court for the Southern District of New York considered the bona fides of an involuntary chapter 11 petition filed by certain holders of U.S. dollar-denominated notes against a holding company for a group of Chinese property development companies that filed a restructuring proceeding in the Cayman Islands after the noteholders filed the involuntary chapter 11 petition. The court denied the debtor's motion to dismiss the chapter 11 case. Given the timing of the filing of the Cayman Islands restructuring proceeding, the absence of any progress in the proceeding for seven months, the debtor's need to restructure notes governed by U.S. law, and the debtor's lack of any meaningful contacts to the Cayman Islands, dismissal of the chapter 11 case was unwarranted under the applicable provision of the Bankruptcy Code, international comity, or the doctrine of forum non conveniens. [read more …] Bankruptcy Court Evaluates Trustee's Authority to Sell Avoidance Actions and Right of Target Defendants to Object In In re Law Enf't Officers Sec. Union, No. 24-70277-JAD, 2026 WL 560452 (Bankr. W.D. Pa. Feb. 27, 2026), a chapter 7 trustee sought court approval to sell certain avoidance actions to a creditor of the debtor's estate. Potential targets of the subject avoidance actions objected, arguing that such claims were nontransferable powers of the trustee rather than saleable estate property and urging the court to approve their competing settlement with the trustee. The U.S. Bankruptcy Court for the Western District of Pennsylvania disagreed with the potential defendants, holding that they lacked standing to object to the proposed sale, that avoidance actions are indeed estate property, and that the sale—rather than the settlement—best served the estate's interests. [read more …] U.S. Supreme Court Bankruptcy Roundup in Brief In Keathley v. Buddy Ayers Construction Inc., No. 25-6, 2026 WL 1686028 (U.S. June 11, 2026), the U.S. Supreme Court overturned a Fifth Circuit decision judicially estopping a chapter 13 debtor from asserting a personal injury claim against a construction company because the debtor failed to disclose the claim during his bankruptcy case. In so ruling, the Court held that "[t]he Fifth Circuit erred by artificially narrowing its inquiry to whether the debtor had knowledge of the underlying facts or a potential motive to conceal the claim." It represents the first time that the Court has applied judicial estoppel in the bankruptcy context, although it has suggested in other contexts that it may be inappropriate where an inconsistent legal position resulted from "inadvertence or mistake." Also in June, the Court denied petitions for certiorari in a few notable bankruptcy cases. [read more …] Newsworthy Heather Lennox (Cleveland/New York) (Star Individual), Bruce Bennett (Los Angeles) (Senior Statesperson), Kevyn D. Orr (Washington) (Eminent Practitioner), Gregory M. Gordon (Dallas) (Band 1), Carl E. Black (Cleveland), Corinne Ball (New York) (Senior Statesperson), Brad B. Erens (Chicago), Jeffrey B. Ellman (Atlanta), T. Daniel Reynolds (Cleveland), and Dan T. Moss (Washington/New York) were recognized as leading lawyers in the practice area Bankruptcy/Restructuring in the 2026 edition of Chambers USA: The World's Leading Lawyers for Business. The 2026 edition of Lawdragon 500 Leading Bankruptcy and Restructuring Lawyers ranked the following lawyers: Corinne Ball (New York) (Hall of Fame), Bruce Bennett (Los Angeles), Carl E. Black (Cleveland), Jeffrey B. Ellman (Atlanta), Brad B. Erens (Chicago), Gregory M. Gordon (Dallas), Heather Lennox (Cleveland/New York), Joshua M. Mester (Los Angeles), and Kevyn D. Orr (Washington). Fabienne Beuzit (Paris) and Jasper Berkenbosch (Amsterdam) were among the "Leading Individuals" ranked in the 2026 edition of The Legal 500 EMEA guide in the field of Restructuring and Insolvency or Insolvency. Rodolphe Carrière (Paris) was named a "Next Generation Partner" in the practice area Insolvency. Sid Pepels (Amsterdam) was selected by Global Restructuring Review's 40 under 40 2026. He was identified as a Rising Star within the global cross-border restructuring community. Global Restructuring Review is a leading digital subscription service, news outlet, and information platform dedicated exclusively to cross-border insolvency and corporate restructuring law. Fabienne Beuzit (Paris), Rodolphe Carrière (Paris), and Isabelle Maury (Paris) were recognized in the 2027 edition of The Best Lawyers in France™ in the practice area Insolvency and Reorganization Law. An article written by Corinne Ball (New York) titled "Comity and Fairness are Critical to Granting Additional Assistance under Chapter 15: A Canadian Reverse Vesting Order and Related Releases in Proceedings Involving Canadian and U.S.-Affiliated Companies Are Approved" was published in the June 24, 2026, edition of the New York Law Journal. An article written by Caitlin K. Cahow (Detroit) titled "New York Bankruptcy Court Weighs In on Adequate Assurance of Future Performance under Assigned Leases and Chapter 11 Plan Exculpation Provisions" was published on June 8, 2026, in Lexis Practical Guidance. An article written by Trisha L. Mowbray (Real Estate; Chicago) and Ryan Sims (Washington) titled "Chapter 11 Plan that Abridged Non-Debtor Lessee's Rights to Remain in Possession After Rejection Unconfirmable as Having Been Proposed in Bad Faith" was published on June 16, 2026, in the Harvard Law School Bankruptcy Roundtable. An article written by Dan T. Moss (Washington/New York), Corinne Ball (New York), Isel M. Perez (Miami), and David S. Torborg (Washington) titled "Texas Bankruptcy Court Adopts Barnet Rule Requiring Foreign Debtor to Have U.S. Assets to Be Eligible for Chapter 15 Relief" was published on June 10, 2026, in Lexis Practical Guidance. An article written by Daniel J. Merrett (Atlanta) and Nathaniel Parr (Atlanta) titled "Southern District of Texas Clarifies Post-Purdue Course for Consensual Third-Party Releases and Gatekeeping Provisions" was published on June 11, 2026, in Lexis Practical Guidance. An article written by Corinne Ball (New York) titled "LMEs, Sophisticated Investors and Equitable Mootness: The Fifth and Third Circuits Warn Against Testing the Limits of Chapter 11" was published in the June 2026 issue of the American Bankruptcy Institute Journal. Nicholas J. Morin (New York) was quoted in an article titled "Serta Ruling Offers Damages Road Map in Lender-on-Lender Disputes," published by Bloomberg Law on July 7, 2026. The article discussed U.S. Bankruptcy Judge Christopher Lopez's July 7, 2026, ruling that participating lenders in Serta Simmons Bedding's 2020 non-pro rata uptier exchange breached the credit agreement's ratable-sharing provision, and awarding excluded lenders more than $261 million in damages. The opinion resolves six years of litigation related to Serta's 2020 transaction, where it raised $200 million in new financing and exchanged $1.2 billion of term loans for $875 million in superpriority debt. Judge Lopez found that the debt-for-debt exchange constituted a "payment" under the credit agreement, requiring proportional sharing among lenders, and dismissed various defenses raised by the participating lenders. The case is Serta Simmons Bedding LLC v. AG Centre Street Partnership (In re Serta Simmons Bedding LLC), 2026 WL 1968535 (Bankr. S.D. Tex. Jul. 7, 2026). The New York Law Journal has recognized Andrew M. Butler (New York) as a 2026 "Rising Star" in Restructuring/Bankruptcy as part of the New York Legal Awards. The Rising Star category recognizes New York's most promising lawyers age 40 and under who have distinguished themselves through exceptional legal work, leadership, and contributions to the profession. Lawyer Spotlight: Daniel J. Merrett Dan Merrett, a partner in the Atlanta Office, has spent nearly 20 years representing all manner of stakeholders in complex corporate restructurings and chapter 11 reorganizations. His practice extends to related transactions and disputes involving acquisitions; divestitures; credit facilities; securities; environmental obligations; and vendor, employee, and governance matters. Dan has substantial experience managing mass tort liabilities, including the restructurings and related chapter 11 cases of affiliates of Georgia Pacific and Johnson & Johnson, implemented to resolve asbestos and talc liabilities. He also represents key parties in energy and infrastructure matters, including facility owners, EPC contractors, and joint-venture parties. Dan was a key player in the restructuring teams in the historic bankruptcies of the City of Detroit and Chrysler. His other significant representations in chapter 11 cases include AFA Foods, Alpha Natural Resources, Dana Corporation, M&G Chemicals, McDermott International, Monster/CareerBuilder, Transtar Industries, and Westinghouse. He is licensed in both the United States and England & Wales and recognized in restructuring by Chambers USA and Best Lawyers.
Here's what tariffs have cost our small business
If we are uncertain whether tariffs will rise again, we become even more cautious.
Court orders Instagram and Facebook's Meta to pay $567M to address kids' mental health online
Judge Bryan Biedscheid said in a ruling late Thursday that the bulk of the money will be used for treatment services for young people.
The Company Behind Ugly Gold Phones Is Now Making Ugly Gold Smart Glasses
Ray-Ban Meta AI glasses are getting the Caviar treatment.
Andrea Hennigan testifies on Lindsay Clancy's mental health and postpartum treatment
Registered nurse Andrea Hennigan testifies about her former colleague Lindsay Clancy. She describes Clancy's struggles with postpartum anxiety, insomnia, and medication side effects prior to January 2023.
AHF • ‘We the People’ Coalition Merges Faith & Politics to Engage Black Voters -- L.A. Gospel Concert & Panel, Sat., Aug. 8th
AIDS Healthcare Foundation (AHF), the world's largest HIV/AIDS healthcare organization, currently provides medical care and services to more than 1.75 million clients in 45 countries. With more than 7,000 employees worldwide, AHF now has treatment clinics and other operations in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth, and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.
Nearly half of dementia cases may be linked to risks you can change
A long-term brain study found that common risks such as smoking, high blood pressure, heart disease, and high blood lipids were strongly linked to damage associated with vascular dementia. The findings suggest that healthier lifestyle choices could help delay dementia by reducing several harmful brain changes at once.
Aware Recovery Care Caught in Multiple Financial, Operational Crises
Aware Recovery Care, a Connecticut-based addiction treatment provider with locations in 11 states, is embroiled in a tangle of legal issues and lost
NYC Health + Hospitals/Jacobi Unveils Art Exhibit for Behavioral Health Patients with Ribbon Cutting Ceremony
Bronx, NY – NYC Health + Hospitals/Jacobi’s Comprehensive Addiction Treatment Center (CATC) unveiled a new art exhibit from NYC Health + Hospitals’ art
Alec Baldwin’s daughter Ireland reacts to Perez Hilton’s hospitalization after his ‘unforgivable’ treatment of her
“I hope he gets the help he needs and heals,” wrote Ireland, who also dubbed the celebrity blogger “a despicable human being.”
Sanofi suspends chronic lung disease phase 2 study, tied to ‘strategic business reasons’
Sanofi halted a phase 2 trial testing a monoclonal antibody, SAR445399, in non-cystic fibrosis bronchiectasis, Fierce Biotech has learned. The trial, which began only back in April, was a randomized, double-blind, placebo-controlled study to measure the reduction in mucus plug score following treatment with SAR445399 compared with placebo in adults aged 18 to 80 years with NCFB, a chronic lung disease. The trial was officially reported as halted on July 29, the day before Sanofi’s second-quarter earnings call. The decision to pause the trial was made “as part of a company-wide portfolio review for strategic business reasons,” and not due to safety concerns, a Sanofi spokesperson told Fierce. The move to pause the NCFB trial comes during a trying time for Sanofi following a year filled with a series of trial fails. In February, the French pharma ousted CEO Paul Hudson and appointed Merck KGaA leader Belén Garijo, M.D., Ph.D., to steer the ship. Since then, Garijo has been doing a deep dive on correcting the company’s strewn R&D and clinical strategies. On July 24, Sanofi scrapped amlitelimab for atopic dermatitis, despite its lore as being a potential $5 billion blockbuster. During its second-quarter report, the company abandoned two more assets, balinatunfib and itepekimab, following failed trial results in psoriasis and chronic obstructive pulmonary disease, respectively. SAR445399, only first revealed by Sanofi in 2023, is an anti-interleukin-1 receptor 3 monoclonal antibody developed to block the interleukin 1, 33, and 36 cytokine pathways. These pathways can be important in chronic immune-related dermatologic diseases, such as atopic dermatitis and hidradenitis suppurativa, as well as respiratory conditions, such as NCFB. Related Sanofi’s new CEO ‘looking deeply’ at late-stage pipeline as clinical clearout continues NCFB affects roughly half a million people in the U.S., with a global incidence of greater than one million cases. In August 2025, Insmed received FDA approval for Brinsupri, a DPP1 inhibitor targeting neutrophil activation, for treatment of NCFB in adults and kids ages 12 and older. The British biotech Infex Therapeutics showed promising NCFB phase 2a data using their monoclonal antibody, INFEX702, which acts by disabling Pseudomonas aeruginosa, a bacteria known to be a major pathogen of NCFB. Sanofi is currently running a separate phase 2 study testing SAR445399 as a potential treatment for the inflammatory skin condition hidradenitis suppurativa.
Team's AI agent to speed Alzheimer's treatment
Vanderbilt researchers have received a grant to build an AI tool within the health record system to get patients with Alzheimer's disease to treatment faster.
Cold Spring Harbor Laboratory and Northwell Health lead international cohort of researchers to develop more than 150 next-generation cancer treatment models
Human Cancer Model Initiative releases compendium results of decade-long project to create cancer organoids Ten years and thousands of patient samples later, the National Cancer Institute (NCI) has just published its results from the Human Cancer Model Initiative (HCMI) on the development of 665 organoid models of 25 types of cancer that are now available...
THC medication made PTSD nightmares disappear for more than a third of patients
A prescription form of THC helped many people with PTSD escape recurring trauma-related nightmares, with more than one-third reporting that the nightmares disappeared completely after ten weeks. The results could point toward a long-awaited treatment for one of PTSD’s most distressing and stubborn symptoms.
'Brazilian blow-drying treatments ruined my life'
Former hairdresser Louisa Curtis says exposure to formaldehyde gas left her unable to work.
AI generates personalized radiopharmaceutical therapy doses in under 23 seconds
The model has the potential to improve upon the one-size-fits-all dosing approach used for most RPT prostate cancer treatments.
Stanford scientists discover immune cells that explode like microscopic bombs
Stanford researchers discovered immune cells in flatworms that explode within minutes, killing nearby bacteria and foreign cells before vanishing completely. Their unusually fast and localized attack could offer clues for developing targeted treatments against infections and cancer.
Downtown attacks prompt civic leaders to hold public safety meetings
Leaders in government, business, and law enforcement will gather on Wednesday in the biggest summit to address the issue since last fall.
CFP bracket predictor: Where the preseason rankings get it wrong
Don’t automatically slot teams from the preseason poll into the 12 precious spots of the College Football Playoff. Let's play CFP predictor!
India: Cockroach Protests Show Political Atmosphere Has Changed
If Modi responds to the Cockroach protesters with further repression, it could backfire.
Xbox's FanFest world tour is still going ahead, for some reason, even after Microsoft fired the guy who created it
"How about those layoffs!" One can only imagine the atmosphere there.
In New York, Mental Health Diversion Depends on Your County
Half of New York counties lack mental health courts, limiting treatment-based alternatives to jail.
Ernst Names Small Business of the Week, Present Company
Read the release on Sen. Ernst's website here. Throughout this Congress, Chair Ernst plans to recognize a small business in every one of Iowa’s 99 counties. RED OAK, Iowa – U.S. Senator Joni Ernst (R-Iowa), Chair of the Senate Small Business Committee, today announced her Small Business of the Week: Present Company of Audubon County. Throughout the 119th Congress, Chair Ernst plans to recognize a small business in each of Iowa's 99 counties. "Present Company has been the gift that keeps on giving to Audubon for more than three decades," said Chair Ernst. "From helping revitalize Main Street to supporting countless local events and charities, Telia Carter and her team continue to present the very best of Iowa's entrepreneurial spirit. Their commitment to exceptional service, unique products, and hometown values proves that investing in your community always comes back around." Founded in 1990 by Nancy Oleson, Present Company opened its doors in downtown Audubon as a home décor boutique. After more than three decades of serving southwest Iowa, ownership transitioned in 2022 to Telia Carter. Under her leadership, Present Company has continued its tradition of personalized customer service while adapting its inventory to meet the needs of customers from Audubon and the surrounding communities. Today, Present Company remains a downtown Audubon staple, offering a carefully curated selection of gifts, home décor, apparel, jewelry, and specialty items. The boutique has earned a reputation for unique merchandise, friendly service, and a welcoming atmosphere that reflects the character of small-town Iowa. Stay tuned as Chair Ernst continues to recognize outstanding Iowa small businesses with her Small Business of the Week award. ###
Rep. Edwards’ behavior with staffers violated House code of conduct, panel finds
The House Ethics Committee released a report Monday in its investigation into the western North Carolina lawmaker's treatment of two female staffers.
Trump administration sued for banning gender transition treatments in federal health plans
An arm of the Human Rights Campaign launched a class-action lawsuit on Monday challenging the Trump administration’s gender-affirming care coverage ban in federal workers’ health insurance plans.&n…
SAMHSA awards $73 million in grants for children’s mental health, other programs
The Substance Abuse and Mental Health Services Administration announced July 31 that it awarded $73.2 million in grants for children’s mental health, suicide prevention and assisted outpatient treatment programs.
New study torpedoes mental health treatment mandate
The first-of-its-kind evaluation of Kendra’s Law was commissioned at the direction of the state Legislature.
Scientists Find Evidence Suggesting Atmosphere On Habitable "Super-Earth"
Astronomers have discovered more than 6,200 exoplanets since the first ones were found in the 1990s.
Giant waves are sweeping Mars’ atmosphere into space
The solar wind may be stripping away Mars’ atmosphere by creating giant rolling waves along its outer edge. Data from MAVEN and Tianwen-1 show that these waves form plasma clouds that carry atmospheric particles into space. The process is concentrated on one side of Mars and may have played a major role in drying out the once potentially habitable planet.
Intermountain Health introduces new pancreatic cancer drug in western Colorado
Cancer center offering first-in-class treatment shown to more than double patients' expected length of life
Johnson County Criminal Mental Health Court would offer treatment plans instead of jail time
Johnson County is considering adding a criminal mental health court program aimed at helping repeat offenders with serious mental illness.
Cancer may be breaking its own DNA to keep growing
Cancer cells rely on powerful genetic switches to keep growth genes running at full speed, but that intense activity can damage their own DNA. The resulting breaks are repeatedly repaired, sometimes with small mistakes that allow new mutations to accumulate. Researchers believe this self-inflicted damage may help tumors evolve while also creating a potential target for new treatments.
Panama: Haemophilus influenzae meningitis case reported in Veraguas Health Region
The Veraguas Health Region, located in the central-western region of Panama, confirmed a case of meningitis caused by the Haemophilus influenzae bacteria in a 12-year-old student from La Primavera School, diagnosed on July 29. The patient remains hospitalized, is receiving appropriate treatment, and is in stable clinical condition. The regional health director of Veraguas, Xavier A. Torres Domínguez, reported that, once the diagnosis was confirmed, the Ministry of Health (Minsa), in coordination with the Social Security Fund (CSS), immediately activated the epidemiological investigation and health response protocols established for this type of event. Canada: Haemophilus influenzae type B outbreak in Calgary As part of the actions implemented, the Epidemiology teams carried out the identification and monitoring of the patient’s close contacts, applying the corresponding preventive measures to reduce the risk of transmission and safeguard the health of the educational community. Health authorities explained that meningitis caused by Haemophilus influenzae is a bacterial disease that requires timely medical attention. In that regard, they urged the population to immediately seek medical attention if they experience symptoms such as high fever, severe headache, stiff neck, vomiting, drowsiness, or altered mental status. They also reiterated that vaccination is the main preventive measure against this disease, and therefore called on parents and guardians to verify that their children’s immunization schedules are complete, in accordance with the Expanded Program on Immunization (EPI). Outbreak News Today is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe
Minnesota's ban on crypto ATMs goes into effect after citizens report losing nearly $1 million in scams
Minnesota's ban on crypto ATMs went into effect on Saturday, and by Dec. 31, all existing machines across the state must be removed.
Saturday Northern Lights Forecast: 10 States May See The Aurora Borealis Tonight
Friday, Saturday and Sunday have all shared forecasts of mild auroral activity around the northern U.S. border, according to the National Oceanic and Atmospheric Administration.
Could we prevent dementia? A new trial may point the way.
While much funding for dementia research goes toward treatments, some scientists want to reduce people's risk of developing the condition in the first place.
Scientists may have found a way to prevent statin muscle pain
Scientists have identified an immune response that may explain why statins cause muscle pain, weakness, and exercise intolerance in some people. The finding could eventually lead to treatments that protect muscles while preserving the drugs’ lifesaving cardiovascular benefits.
FDA clears autoinjector drug for home treatment of heart failure edema
A new drug delivery system may help reduce heart failure hospitalizations and related healthcare costs, which are expected to reach $70 billion by 2030.
Beyond 'healthy' obesity: New framework weighs organ damage and daily limitations
A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by focusing on the effects of excess adiposity on organs and tissues rather than ...
SAMHSA Awards $73.2 Million for Mental Health Treatment and Suicide Prevention Programs
HHS announced awarded $73.2 million in grants to strengthen children’s mental health services, suicide prevention programs.
Molten, Mushy Planet
35 light years away from Earth is a planet a bit bigger than ours that’s probably not hospitable to life -- because it’s molten. Scientists have known about L98-59d for years, but new observations from the James Webb Space Telescope helped reveal an atmosphere rich in hydrogen sulfide, which could only be explained if the planet was in a rare molten state. Living on Earth’s El Wilson and Bella Smith teamed up on this note on emerging science.
ATM stolen from business in downtown Chicago
An ATM was taken during a smash-and-grab burglary in Chicago's Loop early Friday morning.
Does public health *need* MAHA?
Last week, our friend Dr. Craig Spencer sparked an ongoing volatile discussion with his Atlantic article “Public Health Needs MAHA.” Some have come out in strong dissent, others are cheering, and others are simply lamenting that we find ourselves in such a divided world to begin with. We will dare to dip our toes in these controversial waters, too. Does public health need MAHA? We think in some ways yes, and in other ways, no. MAHA leaders versus the everyday MAHA supporter The vitriol in this debate mostly comes from one collapsed distinction: the leadership of MAHA is not necessarily the same as the people who support it. Say “MAHA” and most people picture RFK Jr. Fair enough, as he coined the term and holds most of the power. And, yes, some MAHA followers treat Kennedy as something close to a saint. But talk to the grassroots, and it’s not a monolith. They’re Republicans, Democrats, and Independents. People who distrust vaccines and vaccine supporters. It’s a wide, eclectic coalition. The data backs this too: 4 in 10 Americans support the movement—that’s a lot of people! But according to polls, vaccines and medical choice (the issues most tied to Kennedy personally) are cited by only 4% as their reason for supporting the movement. For many, the motivations are much broader. Many MAHA supporters are signing up for the idea that “something needs to change” with health in this country. They’re asking good-faith questions about corporate influence on our health systems, health care costs, nutrition, chemicals, and clean air and water. These are all questions that plenty of public health professionals recognize as legitimate and also care about very deeply. Blurring the lines between the leadership and grassroots does real damage in two important ways: It hands the 4 in 10 exactly the narrative already fed—that the health ecosystem doesn’t listen, doesn’t care, and paints every critic with the same brush. It gives the actual bad actor more power. RFK Jr. has done irreparable damage and can’t be trusted. What the MAHA movement gets right A healthy population is something the public health field was literally built on, and many of these topics are things we have dedicated our lives to. Yet the MAHA movement has captivated nearly half the country in a way the public health establishment has failed to achieve. So that means MAHA is doing something right. Some of it may be timing (after a Covid-19 pandemic and deep frustration and mistrust with institutions). The movement also does three other things really well: 1. It gives a new, louder voice to system failures. While MAHA is not a monolith, one theme stays consistent across their stories: the system failed them. For some, it was the system that flooded their communities with opioids and then walked away. For others, it was the system that let their business collapse during Covid with no safety net in sight. For others still, it was the system that failed to help them manage a complex chronic illness, bouncing them from physician to physician without any real answers. And in many ways, our health ecosystems are failing Americans. Why are medical bills so incomprehensible? Why do some kids get a healthy school lunch and others don’t? Why do an epidemiologist and a MD/PhD student have to start newsletters in the middle of the biggest public health emergency in a century, just so people can get straight information? Because the systems failed. This deep-seated frustration driving many Americans to search for solutions elsewhere needs to be recognized. 2. MAHA has brilliant comms central to their efforts. MAHA figured out something most health institutions still have not: the information landscape changed. It’s participatory now, not top-down; influence runs through many nodes in a community, not one institution; and storytelling and telling audiences “what you really think” moves people more than data dumps do. MAHA goes where audiences are listening, using podcasts, social media, and memes in ways most health institutions would scoff at—but it works. 3. They are very good at organizing. A MAHA meeting feels like a rally: energy, speakers, music, and most importantly, an action for everyone. Someone’s writing the next policy brief, someone’s seeding a narrative, someone knows the next legislative deadline, someone’s sending the text messages for a campaign. None of this is new (ask the civil rights movement), but MAHA knows it works and has capitalized on it. What MAHA gets wrong This list could be much longer, and this newsletter has spent a lot of time covering it, but here are a few things: Poor use of scientific evidence. This is the fundamental problem with many MAHA policies: the hype outpaces the science, and experts are often villainized for pointing this out. MAHA leadership has traded real solutions for cheap wins. For example, instead of taking on the powerful food industry and passing real reforms, it has celebrated french fries made of beef tallow and taken out artificial dyes from still very sugary children’s cereal. These changes won’t move the needle on America’s diet. MAHA leadership has tried to dismantle vaccine access in the U.S. While many MAHA supporters emphasize other issues, the effort to change vaccine policy has become MAHA’s signature effort. This is not surprising given RFK Jr.’s extensive track record campaigning against vaccines. It has rallied behind the wrong leader. RFK Jr. has a decades-long track record of villifying doctors, scientists, and public health workers, well before he became HHS secretary. He is known for his decades-long work sowing distrust in vaccines as well as life-saving treatments like antiretroviral therapy for HIV. This is not a serious person who can move the needle on health in the U.S, and he has already done serious damage. Public health needs more than defense Defending the evidence is absolutely necessary so health in the U.S. doesn’t move further backward. The public health establishment is very good at defense. The problem is this defense often sounds like defending the status quo, which has failed many people. Public health needs to offer an alternative to RFK Jr.’s MAHA—one that is rooted in evidence, truly listens to and addresses people’s frustrations, and has innovative solutions and the courage to change the systems. How do we get there? Find common ground. Do you know what most people care most about? The abysmal cost of healthcare. Start there. Fight for the human loudly. Too often, communications and engagement center on science with a capital S, funding mechanisms, or the CDC/FDA/NIH. Not the person. So the public doesn’t see themselves in it. Instead, they see people fighting for the very powerful systems that they feel negatively impact their health and well-being. Let the public feel and hear that you see their frustrations, you get it, and you’re fighting for them within the system. Recognize when pro-science messages are alienating people. Facts absolutely matter, but angrily venting only alienates people further. Our friend Elisabeth Marnik recently wrote a New York Times article about her experience growing up unvaccinated and how listening and empathetic conversation are the only ways to reach people that really work (a position backed by communication science). Her comments section was full of hateful comments from pro-vaccine individuals attacking her for daring to suggest we approach vaccine-hesitant individuals with empathy. It is possible to both stand firm behind scientific evidence and empathize with people who don’t trust it. Lean into politics smartly. Often, public health has shied away from politics: Don’t touch it, lest you get burned. But this fails to recognize that the third rail is what fuels the train: who is elected determines our budgets, our priorities, and our authority. Being political means being very savvy in strategy on both sides of the aisle, knowing your audience, and recognizing that political capital is as scarce as financial resources and needs to be allocated accordingly. Bottom line So does public health need MAHA? That’s not really the right question. Public health has a responsibility not to dismiss 40% of the country who feel heard by this movement and are frustrated that the system has failed them. And it has a responsibility to stick to the evidence and recognize MAHA leadership for what it is: a danger to our nation’s health. Both can, and should, be done. Love, YLE and KP A big thanks to Craig Spencer, who had the courage to put his neck out there to start a much-needed discussion at such a critical moment—one that is determining the identity of an entire field. Kristen Panthagani, MD, PhD is completing an emergency medicine residency and research fellowship focusing on health literacy and communication. In her free time, she writes the newsletters You Can Know Things debunking health myths and rumors and The Public Health Roundup. Views expressed belong to KP, not her employer. Your Local Epidemiologist (YLE) comprises a team of experts, ranging from physicians to immunologists to epidemiologists to nutritionists, working together with one goal: to “translate” ever-evolving public health science so that people are well-equipped to make evidence-based decisions. The YLE suite of newsletters reaches over 475,000 people across more than 132 countries. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
LMH Health doctors provide insight into taking care of your heart
Heart disease continues to be the leading cause of death in the United States, according to the American Heart Association’s 2026 annual report. Despite advances in technology and treatment, prevention and early detection are essential. It’s important to know more about a heart-healthy lifestyle and the signs and symptoms to look for. For those without heart […]
The Real Antidepressant Crisis
Robert F. Kennedy Jr. says Americans overuse SSRIs. In fact, too many people who need depression treatment aren’t getting any.
A.14 Atmosphere Several Corrections
The Earth Science Division recently released A.14 Atmosphere, soliciting proposals for data analysis and modeling of NASA supported airborne campaign data.
Journal, university investigations launched into gene-editing death following Science-Retraction Watch reporting
Nature is investigating concerns surrounding a paper at the heart of a news story published last week on the death of a 6-year-old girl following a gene therapy treatment in China. The paper, publi…
Flawed studies linking hormone therapy to breast cancer made doctors reluctant to prescribe it for menopause relief – especially for breast cancer survivors
Menopausal hormone therapy no longer has the highest-level warning label about the risk of breast cancer, opening a gray area on who would benefit most from treatment.
Why are biomedical scientists being vilified?
Protect those scientists who provide the underlying research that can continue furthering progress toward lifesaving preventions and treatments
Florida urges doctors not to prescribe mental health medication for children
Florida's surgeon general has warned doctors not to prescribe antidepressants and other psych drugs for children, instead urging comprehensive evaluations and behavioral therapy as first line treatment options.
Enzyme ratio could help cardiologists track risk of stroke, AFib after TAVR
The De Ritis ratio could be a new way to anticipate when TAVR patients may face certain short-term risks after treatment.
My daughter's squishy toy exploded in the car and burned her
Kimmie Staggs says a squishy toy burst after heating up in her car, leaving her teenage daughter with burns that required emergency treatment.
National healthcare groups join HHS effort to improve behavioral health, addiction care
The Health and Human Services Secretary today announced that dozens of insurers, medical societies, healthcare providers and behavioral health experts have pledged to strengthen the nation’s behavioral health system by advancing best practices aimed at improving mental health and addiction treatment.
Killing slime: an AI-first biotech solution | Investors Lab
We love public science lessons, like the algae debacle that turned Washington, D.C.'s Lincoln Memorial Reflecting Pool a vibrant green this summer after a renovation. It's not exactly a new development. Algal blooms have intermittently plagued the site for generations, including during the last big overhaul in 2012. But the latest episode lingers despite treatments with hydrogen peroxide and an ozone nanobubble system. As Bethany Brookshire makes clear for Science News, there's another option that might have managed the crisis far more effectively, had it been used from the start.
UConn Health Minute: Hypothyroid Study
A UConn Health clinical trial is exploring a promising new treatment option for people with hypothyroidism. Learn how the study aims to improve symptoms and ...
Scientists find a simple way to stop cavities without drilling
A liquid brushed onto cavities in seconds may spare many young children from pain, infection, and surgery. A major U.S. trial found that silver diamine fluoride stopped decay in more than half of treated baby teeth. The treatment requires no drilling, shots, or sedation, although it does permanently darken the decayed area.
A slowing Atlantic current could unleash stronger California storms
A weakening Atlantic current could supercharge California’s atmospheric rivers while leaving Greenland with fewer snow-producing storms. The changes could raise flood risks, strain infrastructure, and reshape water supplies far beyond the Atlantic.
NASA science soars during August total solar eclipse
Each time the moon covers the sun during a total solar eclipse—darkening daytime skies and briefly revealing the sun's ethereal outer atmosphere, the corona—it presents new opportunities to better understand ...
In the Lindsay Clancy trial, mental health treatment is also on the stand
It already worked against Latarsha Sanders, the Brockton mother found guilty of killing her two youngest children.
An entirely new kind of drug will help us treat the untreatable
The first of a new generation of drugs that works in a completely different way to existing ones has been approved. Columnist Michael Le Page says this approach could transform treatments for all kinds of conditions
NASA Science Soars During August Total Solar Eclipse
Each time the Moon covers the Sun during a total solar eclipse — darkening daytime skies and briefly revealing the Sun’s ethereal outer atmosphere, the corona
UT Health San Antonio uncovers potential strategy for safer cancer treatments
Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, July 27, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), have found a potential path to maintaining the cancer-fighting benefits of one type of immunotherapy while limiting harmful […]
AARP Is Working to Change the Culture of Health Care Ageism
Ageism puts your health at risk. AARP is teaching health care workers to avoid it
Scientists have found an Earth-like exoplanet
The super-Earth likely contains an atmosphere
COMMENTARY: Science, Not Politics, Must Guide Lifesaving Medical Research
AFRO-AMERICAN – WASHINGTON — A recent announcement regarding a new treatment for metastatic pancreatic cancer, daraxonrasib, has shown it doubled survival rates for patients and reduced the risk of death by 60 percent. This breakthrough stemmed from sustained, peer-reviewed scientific investment.
Oil price slides as US and Iran pause fire; cancer treatments help AstraZeneca beat profit forecasts
Rolling coverage of the latest economic and financial news
AI mental health chatbots feel empathetic, but safety evidence still lags
Immune dysregulation may contribute to depression, schizophrenia, bipolar disorder, and anxiety through chronic inflammation, altered neuroimmune signaling, genetic susceptibility, and stress-related epigenetic changes. Evidence also suggests that biologically defined patient subgroups may benefit from more precise, immune-informed approaches to diagnosis and treatment.
Puzzles, Treats, and Consent? The New Frontier in Wildlife Studies
From raccoons solving puzzle boxes to dogs leaving saliva samples, scientists are experimenting with less invasive ways to study wildlife.
Chinese scientist faces probe after girl dies ‘after experimental gene therapy’
Shanghai Jiao Tong University says it is investigating after a report alleges the child died after receiving treatment from Qiu Zilong.
U.Va. Health becomes first health system in Virginia to offer new melanoma treatment
U.Va. Health interventional radiologist Dr. Daniel Sheeran and U.Va. Health Cardiac Anesthesiologist Dr. Paul Gallo helped bring the treatment to U.Va. Health.
The shrinking world of former president Joe Biden
Cancer treatment has sharply limited Biden’s post-White House life even as his upcoming memoir threatens to reopen debates over his health and presidency.
The shrinking world of former president Joe Biden
Cancer treatment has sharply limited Biden’s post-White House life even as his upcoming memoir threatens to reopen debates over his health and presidency.
More health workers strike as Ebola cases in Congo near 3,000, including over 1,300 deaths
Health workers at an Ebola treatment center in eastern Congo have gone on strike over payment issues, disrupting patient care.
A hidden Alzheimer’s tipping point may decide who gets dementia
Scientists have identified a possible tipping point that helps determine whether Alzheimer’s-related brain changes lead to dementia. The key may lie in how the brain’s immune cells respond to plaques and tau, offering a promising new target for treatments designed to extend cognitive resilience.
More health workers strike as Ebola cases in Congo near 3,000, including over 1,300 deaths
Health workers at an Ebola treatment center in eastern Congo have gone on strike over payment issues, disrupting patient care.
More health workers strike as Ebola cases in Congo near 3,000, including over 1,300 deaths
Health workers at an Ebola treatment center in eastern Congo have gone on strike over payment issues, disrupting patient care.
More workers strike as Ebola cases in Congo near 3,000, including over 1,300 deaths
Health workers at an Ebola treatment center in eastern Congo have gone on strike over payment issues, disrupting patient care
We need more therapists. They need more power.
Americans are seeking treatment for conditions like anxiety, depression and trauma, only to find the mental health workforce isn't keeping up.
Greene County launches mental health court to divert eligible defendants to treatment
Greene County has launched a new mental health court aimed at keeping eligible defendants out of prison and connecting them with treatment.
6-year-old in China dies after experimental treatment, investigation finds, raising questions about the country's gene therapy regulations
A young girl in China died after being given an experimental gene therapy intended to treat a neurodevelopmental syndrome, an investigation by Science and Retraction Watch revealed.
Government Working for You: Behavioral Health and Substance Use Treatment Services | County News Center | Office of Communications and Public Affairs
draft